NASDAQ · Financial Statements

Apnimed, Inc. (APMD) Revenue, Earnings & Financial Statements

$17.34 NASDAQ: APMD Market Cap $721.78M

Data as of Nov 17, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Apnimed, Inc. most recently reported annual revenue of $38.0M, a net loss of $1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Income Statement — 1 Years (USD millions)

Metric2025
Revenue$38.0M
Operating Expenses$92.0M
Operating Profit−$54.0M
Operating Margin-139.9%
Other Income$53.0M
Interest$0
Depreciation$0
Profit Before Tax−$1.0M
Tax rate (%)0.0%
Net Profit−$1.0M
EPS−$0.03

Quarterly Results — Last 3 Quarters (USD millions)

MetricMar '26Jun '26Sep '26
Revenue$85.0M$12.0M$0
Operating Expenses$17.0M$24.0M$32.0M
Operating Profit$68.0M−$12.0M−$32.0M
Operating Margin80.2%-96.9%—
Interest$0$0$0
Profit Before Tax$70.0M$126.0M−$30.0M
Tax rate (%)0.0%0.0%0.0%
Net Profit$70.0M$126.0M−$30.0M
EPS$2.12$3.16−$1.05

Balance Sheet — 1 Years (USD millions)

Metric2025
Total Assets$73.0M
Current Assets$45.0M
Cash$42.0M
Inventory$0
Receivables$1.0M
Fixed Assets$1.0M
Capital Work in Progress$0
Investments$0
Other Assets$0
Total Liabilities$446.0M
Current Liabilities$111.0M
Borrowings$42.0M
Other Liabilities$404.0M
Equity$0
Reserves−$373.0M

Cash Flow Statement — 1 Years (USD millions)

Metric2025
Operating Cash Flow−$78.0M
Investing Cash Flow$0
Financing Cash Flow$0
Net Cash Flow−$26.0M
Free Cash Flow−$78.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.04
EV / EBITDA16.96
FCF Yield-8.19%
Quick Ratio9.77
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Apnimed, Inc. (APMD) financials — frequently asked questions

What is Apnimed, Inc.'s annual revenue?

Apnimed, Inc. (APMD) reported annual revenue of $38.0M in its most recent fiscal year.

What is Apnimed, Inc.'s net profit?

Apnimed, Inc. (APMD) reported a net loss of $1.0M in its most recent fiscal year.

What is APMD EV/EBITDA?

Apnimed, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 16.96.

Revenue and earnings of other Biotechnology stocks

VRTX revenue $12.1BREGN revenue $14.3BMRNA revenue $1.9BRVMD financialsROIV revenue $8.0MINSM revenue $606.0MUTHR revenue $3.2BINCY revenue $5.1BALNY revenue $3.7BASND revenue $692.0MAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
APMD Overview APMD Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.